Endocrinology, Vol 123, 1676-1681, Copyright © 1988 by Endocrine Society

ARTICLES

Anterior pituitary type II thyroxine 5'-deiodinase activity is not affected by lesions of the hypothalamic paraventricular nucleus which profoundly depress pituitary thyrotropin secretion

M Murakami, K Tanaka, MA Greer and M Mori
Department of Medicine, Oregon Health Sciences University, Portland 97201.

Bilateral destruction of the hypothalamic paraventricular nuclei (PVN) produced a profound depression of plasma TSH and the median eminence TRH concentration in hypothyroid rats. Anterior pituitary type II iodothyronine 5'-deiodinase (5'-D) activity was consistently lower but not significantly different in sham- and PVN-lesioned rats. Treatment with suboptimal replacement doses of 0.15 and 0.75 micrograms T4/100 g BW.day produced a graded depression of plasma TSH in the PVN (P less than 0.02), but not in the sham (P greater than 0.8) groups. Adenohypophyseal 5'-D was depressed in both sham and PVN groups by the highest T4 dose. Plasma T4 was much lower in PVN than in sham rats given comparable doses of T4 (P less than 0.001), but plasma T3 was not significantly different. This suggests that an increase in peripheral T4 metabolism was produced by PVN lesions. Our data indicate that changes in adenohypophyseal 5'-D activity are not responsible for the decrease in plasma TSH in PVN-lesioned rats and that neither the PVN nor endogenous TRH plays a significant role in the regulation of anterior pituitary 5'-D activity.

This article has been cited by other articles:

				T. Morimura, K. Tsunekawa, T. Kasahara, K. Seki, T. Ogiwara, M. Mori, and M. Murakami Expression of Type 2 Iodothyronine Deiodinase in Human Osteoblast Is Stimulated by Thyrotropin Endocrinology, April 1, 2005; 146(4): 2077 - 2084. [Abstract] [Full Text] [PDF]

				O. Araki, T. Morimura, T. Ogiwara, H. Mizuma, M. Mori, and M. Murakami Expression of Type 2 Iodothyronine Deiodinase in Corticotropin-Secreting Mouse Pituitary Tumor Cells Is Stimulated by Glucocorticoid and Corticotropin-Releasing Hormone Endocrinology, October 1, 2003; 144(10): 4459 - 4465. [Abstract] [Full Text] [PDF]

				C. A. Everson and T. S. Nowak Jr. Hypothalamic thyrotropin-releasing hormone mRNA responses to hypothyroxinemia induced by sleep deprivation Am J Physiol Endocrinol Metab, July 1, 2002; 283(1): E85 - E93. [Abstract] [Full Text] [PDF]

				H. Mizuma, M. Murakami, and M. Mori Thyroid Hormone Activation in Human Vascular Smooth Muscle Cells : Expression of Type II Iodothyronine Deiodinase Circ. Res., February 16, 2001; 88(3): 313 - 318. [Abstract] [Full Text] [PDF]

				M. Murakami, O. Araki, T. Morimura, Y. Hosoi, H. Mizuma, M. Yamada, H. Kurihara, S. Ishiuchi, M. Tamura, T. Sasaki, et al. Expression of Type II Iodothyronine Deiodinase in Brain Tumors J. Clin. Endocrinol. Metab., November 1, 2000; 85(11): 4403 - 4406. [Abstract] [Full Text]

				Y. Hosoi, M. Murakami, H. Mizuma, T. Ogiwara, M. Imamura, and M. Mori Expression and Regulation of Type II Iodothyronine Deiodinase in Cultured Human Skeletal Muscle Cells J. Clin. Endocrinol. Metab., September 1, 1999; 84(9): 3293 - 3300. [Abstract] [Full Text]